Low-density lipoprotein (LDL) oxidizability before and after LDL apheresis

Metabolism: Clinical and Experimental

Volumn 48, Issue 7, 1999, Pages 881-886

  Donner, Markus G ^a   Parhofer, Klaus G ^a   Richter, Werner O ^a,b   Schwandt, Peter ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b Inst Lipoprotein Metab H   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; APHERESIS; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; COMPUTER SIMULATION; FAMILIAL HYPERCHOLESTEROLEMIA; FAST PROTEIN LIQUID CHROMATOGRAPHY; FATTY ACID METABOLISM; FEMALE; HUMAN; LIPID OXIDATION; LIPOPROTEIN METABOLISM; MALE; PRIORITY JOURNAL;

EID: 0033039949     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(99)90223-8     Document Type: Article

References (32)

1. Stary HC: Evolution and progression of atherosclerotic lesions in coronary arteries of children and young adults. Arteriosclerosis 9:19-32, 1989 (suppl 1)
2. Brown MS, Goldstein J: Lipoprotein metabolism in the macrophage. Annu Rev Biochem 52:223-261, 1983
3. Lavy A, Brook GJ, Dankner G, et al: Enhanced in vitro oxidation of plasma lipoproteins derived from hypercholesterolemic patients. Metabolism 40:794-799, 1991
4. Napoli C, Postiglione A, Triggiani M, et al: Oxidative structural modification of low density lipoprotein in homozygous familial hypercholesterolemia. Atherosclerosis 118:259-273, 1995
5. Stalenhoef AF: Clinical implications of increased low-density lipoprotein oxidation in patients with hypercholesterolemia. Nutrition 10:564-566, 1994
6. Kleinveld HA, Demacker PN, De Haan AF, et al: Decreased in vitro oxidability of low-density lipoprotein in hypercholesterolaemic patients treated with 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors. Eur J Clin Invest 23:289-295, 1993
7. Esterbauer H, Dieber-Rotheneder M, Waeg G, et al: Endogenous antioxidants and lipoprotein oxidation. Biochem Soc Trans 18:1059-1061, 1990
8. Packer JE, Slater TF, Wilson RL: Direct observation of a free radical interaction between vitamin E and vitamin C. Nature 278:737-738, 1979
9. Reaven P, Parthasarathy S, Grasse B, et al: Effects of oleate-rich and linoleate-rich diets on the susceptibility of low density lipoprotein to oxidative modification in mildly hypercholesterolemic subjects. J Clin Invest 91:668-676, 1993
10. Mata P, Alonso R, Lopez-Farre A, et al: Effect of dietary fat saturation on LDL oxidation and monocyte adhesion to human endothelial cells in vitro. Arterioscler Thromb Vasc Biol 16:1347-1355, 1996
11. Parthasarathy S, Khoo JC, Miller E, et al: Low density lipoprotein rich in oleic acid is protected against oxidative modification: Implications for the dietary prevention of atherosclerosis. Proc Natl Acad Sci USA 87:3894-3898, 1990
12. Esterbauer H, Gebicki J, Puhl H, et al: The role of lipid peroxidation and antioxidants in the oxidative modification of LDL. Free Radic Biol Med 13:341-390, 1992
13. Stoffel W, Greve V, Borberg H: Application of specific extracorporeal removal of low density lipoprotein in familial hypercholesterolemia. Lancet 2:1005-1007, 1981
14. Eisenhauer T, Armstrong VW, Wieland H, et al: Selective removal of low density lipoproteins (LDL) by precipitation at low pH: First clinical application of the HELP system. Klin Wochenschr 65:161-168, 1987
15. Seidel D, Armstrong VW, Schuff-Werner P, et al: The HELP-LDL-Apheresis Multicenter Study, an angiographically assessed trial on the role of LDL-apheresis in the secondary prevention of coronary heart disease. I. Evaluation of safety and cholesterol-lowering effects during the first 12 months. Eur J Clin Invest 21:375-383, 1991
16. Homma Y, Mikami Y, Tamachi H, et al: Comparison of selectivity of LDL removal by double filtration and dextran-sulfate cellulose column plasmapheresis. Atherosclerosis 60:23-27, 1986
17. Mabuchi H, Michishita I, Takeda M, et al: A new low density lipoprotein apheresis system using two dextran sulfate cellulose columns in an automated column regenerating unit (LDL-continuous apheresis). Atherosclerosis 68:19-25, 1987
18. Richter WO, Jacob BG, Ritter MM, et al: Three-year treatment of familial heterozygous hypercholesterolemia by extracorporeal low-density lipoprotein immunoadsorption with polyclonal apolipoprotein B antibodies. Metabolism 42:888-894, 1993
19. Jacob BG, Richter WO, Schwandt P: Therapy of severe familial heterozygous hypercholesterolemia by low-density lipoprotein apheresis with immunoadsorption: Effects of the addition of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors to therapy. Clin Invest 71:908-912, 1993
20. Napoli C, Ambrosio G, Scarpato N, et al: Decreased low-density lipoprotein oxidation after repeated selective apheresis in homozygous familial hypercholesterolemia. Am Heart J 133:585-595, 1997
21. Leitinger N, Pirich C, Blazek I, et al: Decreased susceptibility of low-density lipoproteins to in-vitro oxidation after dextran-sulfate LDL-apheresis treatment. Atherosclerosis 126:305-312, 1996
22. Cattin L, Petrucco A, Cazzolato G, et al: Low density lipoproteinapheresis decreases oxidized low density lipoproteins and monocyte adhesion to endothelial cells. ASAIO J 43:209-213, 1997
23. Richter WO, Donner MG, Schwandt P: Short- and long-term effects on serum lipoproteins of three different techniques of apheresis. Artif Organs 30:311-317, 1996
24. Esterbauer H, Striegl G, Puhl H, et al: Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radic Res Commun 6:67-75, 1989
25. Vedie B, Myara I, Pech MA, et al: Fractionation of charge-modified low density lipoproteins by fast protein liquid chromatography. J Lipid Res 32:1359-1369, 1991
26. Shimomura Y, Sugiyama S, Takamura T: Quantitative determination of fatty acid composition of human lipids by high performance liquid chromatography. J Chromatogr 383:9-17, 1986
27. Jialal I, Devaraj S: Low-density lipoprotein oxidation, antioxidants, and atherosclerosis: A clinical biochemistry perspective. Clin Chem 42:498-506, 1996
28. Jialal I, Grundy SM: Effect of combined supplementation with alpha-tocopherol, ascorbate and beta carotene on low-density lipoprotein oxidation. Circulation 88:2780-2786, 1993
29. Kesaniemi YA, Vega GL, Grundy SM: Kinetics of apolipoprotein B in normal and hyperlipidemic man: Review of the current data, in Berman M, Grundy SM, Howard BV (eds): Lipoprotein Kinetics and Modeling. New York, NY, Academic, 1982, pp 181-205
30. Parhofer GK, Barrett PHR, Demant T, et al: Effects of weekly LDL apheresis on metabolic parameters of apolipoprotein B in heterozygous familial hypercholesterolemia. J Lipid Res 37:2383-2393, 1996
31. Hermann M, Gmeiner B: Altered susceptibility to in-vitro oxidation of LDL in LDL complexes and LDL aggregates. Arterioscler Thromb 12:1503-1506, 1992
32. Armstrong VW, Niedmann D, Eisenhauer T, et al: Acute and long-term effects of low-density lipoprotein apheresis on serum concentrations of vitamins A and E. Klin Wochenschr 66:123-128, 1988